RCRA Rules

July 23, 2024

Reading Time : 1 min

In February 2024, the U.S. Environmental Protection Agency (EPA) proposed two rules under the Resource Conservation and Recovery Act (RCRA). The first modifies RCRA’s definition of “hazardous waste” as it applies to cleanups at permitted hazardous waste facilities and the second adds nine per- and polyfluoroalkyl substances (PFAS) to the RCRA list of “hazardous constituents.”

RCRA directs EPA to require corrective action for “releases of hazardous waste or constituents from any solid waste management unit” at permitted hazardous waste treatment, storage or disposal facilities as well as off-site where necessary to protect human health and the environment. EPA’s proposed rule would expand the definition of hazardous waste to go beyond wastes listed as hazardous based on certain characteristics (toxicity, corrosivity, ignitability and reactivity) to include and apply it to a broader range of solid wastes that when treated, stored, disposed of or transported improperly can lead to adverse effects on human health or the environment (such as PFAS).

Concurrently, EPA proposes to add nine PFAS, their salts, and their structural isomers, including perfluorooctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), perfluorobutanesulfonic acid (PFBS) and Gen-X to the list of “hazardous constituents” that must be considered in assessments of treatment, storage and disposal facilities (and for which further investigation and cleanup may be necessary through the corrective action process).

The PFAS proposed to be added to the RCRA list of hazardous constituents are:

  1. Perfluorooctanoic acid
  2. Perfluorooctanesulfonic acid
  3. Perfluorobutanesulfonic acid
  4. Hexafluoropropylene oxide-dimer acid
  5. Perfluorononanoic acid
  6. Perfluorohexanesulfonic acid
  7. Perfluorodecanoic acid
  8. Perfluorohexanoic acid
  9. Perfluorobutanoic acid.

Share This Insight

Previous Entries

PFAS Press

November 11, 2025

On November 10, 2025, the U.S. Environmental Protection Agency (EPA) released the pre-publication draft proposed rule to amend the PFAS reporting requirements under TSCA, entitled “Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) Data Reporting and Recordkeeping Under the Toxic Substances Control Act (TSCA); Revision to Regulation.” The proposal aims to augment the exemptions to the scope of the reporting requirements and introduces additional modifications to make the rule “more practical and implementable and reduce unnecessary, or potentially duplicative, reporting requirements for businesses.” Potentially offering even greater flexibility, it concludes with a request for comment on additional provisions. 

...

Read More

PFAS Press

September 16, 2025

On September 4, the U.S. Environmental Protection Agency (EPA) (finally) published its Spring 2025 Unified Agenda of Regulatory and Deregulatory Actions (UA), a semiannual publication outlining federal agencies’ regulatory priorities and timelines for the upcoming year. The UA included a notice of its intent to rescind drinking water limits set by a Biden-era rule for three per- and polyfluoroalkyl (PFAS) substances and one PFAS mixture. EPA also published a notice of intent to retain limits on PFOA and PFOS, although with extended timelines for compliance.

...

Read More

PFAS Press

September 5,2025

On August 20, 2025, Denmark, Germany, the Netherlands, Norway and Sweden submitted an update to the proposal to restrict PFAS under the European Union’s REACH regulation that they originally submitted in January 2023. The revision reflects their comprehensive evaluation of more than 5,000 scientific and technical comments submitted by stakeholders, including industry representatives, researchers and civil society organizations.

...

Read More

PFAS Press

August 6, 2025

On August 6, 2025, the U.S. Food and Drug Administration (FDA) became the latest governmental agency to confirm that fluoropolymers are both safe and necessary. After an independent safety review of fluoropolymers in medical devices showed no conclusive evidence of health issues, FDA concluded that fluoropolymers are “very unlikely to cause toxicity” because of molecular size and further that they are essential for medical devices to function. As a result, “FDA’s evaluation is that currently there is no reason to restrict their continued use in devices.”

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.